Tested Applications
| Positive WB detected in | A431 cells, HepG2 cells, MCF-7 cells, HEK-293 cells |
| Positive IF/ICC detected in | HEK-293 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:8000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
23271-1-AP targets KCNN4 in WB, IHC, IF/ICC, IP, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, canine |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag19774 Product name: Recombinant human KCNN4 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 128-427 aa of BC015337 Sequence: VQDLGAPLTSPQPWPGFLGQGEALLSLAMLLRLYLVPRAVLLRSGVLLNASYRSIGALNQVRFRHWFVAKLYMNTHPGRLLLGLTLGLWLTTAWVLSVAERQAVNATGHLSDTLWLIPITFLTIGYGDVVPGTMWGKIVCLCTGVMGVCCTALLVAVVARKLEFNKAEKHVHNFMMDIQYTKEMKESAARVLQEAWMFYKHTRRKESHAARRHQRKLLAAINAFRQVRLKHRKLREQVNSMVDISKMHMILYDLQQNLSSSHRALEKQIDTLAGKLDALTELLSTALGPRQLPEPSQQSK Predict reactive species |
| Full Name | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
| Calculated Molecular Weight | 427 aa, 48 kDa |
| Observed Molecular Weight | 48 kDa |
| GenBank Accession Number | BC015337 |
| Gene Symbol | KCNN4 |
| Gene ID (NCBI) | 3783 |
| RRID | AB_2879243 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen Affinity purified |
| UNIPROT ID | O15554 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
The intermediate conductance calcium-activated potassium channel KCNN4, also known as KCa3.1, IK1, or SK4, is a member of the potassium channel KCNN family. KCNN4 is expressed in T cells, mast cells, macrophages, erythrocytes, vascular smooth muscle cells, airway smooth muscle cells, intestinal and airway epithelial cells (PMID: 19681865; 21493782). Functionally, KCNN4 plays a key role in calcium-dependent cell functions, such as proliferation, activation, and migration, in a broad range of cell types (PMID: 21493782).
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for KCNN4 antibody 23271-1-AP | Download protocol |
| WB protocol for KCNN4 antibody 23271-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The anti-KCNN4 antibody (Cat# 23271-1-AP) has 15 total citations. These appear in journals including Nature Communications, Journal of Hematology & Oncology, Journal of Biological Chemistry, European Journal of Pharmacology, International Journal of Molecular Sciences, Experimental Cell Research, and others. Research fields span pancreatic cancer, prostate cancer, lung adenocarcinoma, renal cell carcinoma, rheumatoid arthritis, ion channel biology, macrophage polarization, cardiac electrophysiology, and anemia. Applications include WB, IHC, IF, IP, and CoIP in human, mouse, and canine samples.
| Species | Application | Title |
|---|---|---|
J Hematol Oncol The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA | ||
Nat Commun Phospholipid scrambling induced by an ion channel/metabolite transporter complex | ||
Cancer Cell Int KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma. | ||
Eur J Pharmacol Blockade of KCa3.1 ameliorates rheumatoid arthritis by suppressing macrophage M1 polarization via the NLRP3 inflammasome signaling pathway.
| ||
Int J Mol Sci Downregulation of IL-8 and IL-10 by the Activation of Ca2+-Activated K+ Channel KCa3.1 in THP-1-Derived M2 Macrophages |







